Home / Recalls / VIONA PHARMACEUTICALS INC / D-0172-2025

D-0172-2025 Class II Ongoing

Recalled by VIONA PHARMACEUTICALS INC — Cranford, NJ

Recall Details

Product Type
Drugs
Report Date
January 8, 2025
Initiation Date
December 10, 2024
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2760 packs

Product Description

Dapsone Gel 7.5%, 90 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-03. packaged in an Airless pump pack

Reason for Recall

Crystallization

Distribution Pattern

US Nationwide

Code Information

Lots T400514, Exp Date 02/2026 & T400808, Exp Date 03/2026

Other recalls by VIONA PHARMACEUTICALS INC

  • D-0016-2026 Class II — Tavaborole Topical solution 5%, 10 mL bottle, Rx only, Manufactured by: Zydus Li (October 6, 2025)
  • D-0595-2025 Class II — Tavaborole Topical Solution 5%, 10 mL per glass bottle, Rx Only, For Topical Use (August 12, 2025)
  • D-0171-2025 Class II — Dapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Aheme (December 10, 2024)
  • D-0038-2025 Class II — Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd (October 29, 2024)
  • D-0011-2025 Class II — Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd (September 24, 2024)
  • D-0392-2022 Class II — Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count HDPE bot (December 27, 2021)
  • D-0640-2021 Class II — Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 Tablets, Rx on (June 1, 2021)